SEC Filing Summary: Colfax Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Colfax Corporation on March 14, 2012, reporting events occurring on March 9 and March 13, 2012. The filing addresses the exercise of an over-allotment option related to a recent public offering of common stock.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The only specific financial metric disclosed is the aggregate purchase price of the additional shares issued.
- Shares Issued: 1,000,000 additional shares of common stock (Option Shares).
- Aggregate Proceeds: $34,000,000.
- Underwriters: Deutsche Bank Securities Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated.
Material Changes
The material change reported is the increase in outstanding common stock and capital raised following the underwriters' exercise of their over-allotment option. This action completed the public offering initiated under an underwriting agreement dated February 28, 2012.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the completion of the stock issuance. No unusual items were reported.
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance to assess dilution impact.
- Confirm the use of the $34,000,000 in proceeds as disclosed in subsequent filings or press releases.
- Review the original underwriting agreement dated February 28, 2012, for terms regarding the initial offering.
- Note that the company name in the metadata (Enovis CORP) does not match the registrant in the filing text (Colfax Corporation); verify the correct entity for investment analysis.